Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Inflammation
Published in: Inflammation 4/2012

01-08-2012

Effect of Porphyromonas gingivalis and Lactobacillus acidophilus on Secretion of IL1B, IL6, and IL8 by Gingival Epithelial Cells

Authors: Jun-jun Zhao, Xi-ping Feng, Xiu-li Zhang, Ke-yi Le

Published in: Inflammation | Issue 4/2012

Login to get access

Abstract

Porphyromonas gingivalis alters cytokine expression in gingival epithelial cells, stimulating inflammatory responses that may lead to periodontal disease. This study explored the effect of Lactobacillus acidophilus on the specific expressions of the interleukins (ILs) IL1B, IL6, and IL8 induced by the pathogen. Human gingival epithelial cells were co-cultured with P. gingivalis, L. acidophilus, or L. acidophilus + P. gingivalis; the control group consisted of the cells alone. Protein and gene expression levels of the ILs were detected using ELISA and qRT-PCR, respectively. The supernatant from the P. gingivalis group held significantly higher protein and mRNA levels of IL1B, IL6, and IL8, compared to the control group. In the mixed bacterial group (L. acidophilus + P. gingivalis), the levels of all three ILs decreased with increasing concentrations of L. acidophilus and were significantly different from the P. gingivalis group. This suggests that in gingival cells, L. acidophilus offsets the P. gingivalis-induced secretion of these ILs in a dose-dependent manner.
Literature
1.
Houle, M.A., and D. Grenier. 2003. Maladies parodontales: Connaissances actuelles. Current concepts in periodontal diseases. Médecine et maladies infectieuses 33(7): 331–340.CrossRef
2.
Andrian, E., D. Grenier, and M. Rouabhia. 2006. Porphyromonas gingivalis-epithelial cell interactions in periodontitis. Journal of Dental Research 85: 392–403.PubMedCrossRef
3.
Holt, S.C., L. Kesavalu, S. Walker, and C.A. Genco. 2000. Virulence factors of Porphyromonas gingivalis. Periodontology 2000 20: 168–238.CrossRef
4.
Nakagawa, T., A. Saito, Y. Hosaka, et al. 2003. Gingipains as candidate antigens for Porphyromonas gingivalis vaccine. The Keio Journal of Medicine 52(3): 158–162.PubMedCrossRef
5.
Imamura, T. 2003. The role of gingipains in the pathogenesis of periodontal disease. J. Periodontal. 74(1): lll–118.CrossRef
6.
Paramonov, N., D. Bailey, M. Rangarajan, et al. 2001. Structural analysis of the polysaccharide from the lipopolysaccharide of Porphyromonas gingivalis strain W50. European Journal of Biochemistry 268(17): 4698–4707.PubMedCrossRef
7.
Zhang, L.Q., and D.Y. Li. 2008. Antimicrobial defense effects of gingival epithelial cells. International Journal of Stomatology 35(5): 519–522. In Chinese.
8.
Kesavalu, L., B. Chandrasekar, and J.L. Ebersole. 2002. In vivo induction of proinflammatory cytokines in mouse tissue by Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans. Oral Microbiology and Immunology 17: 177–180.PubMedCrossRef
9.
Njoroge, T., R.J. Genco, H.T. Sojar, et al. 1997. A role of fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells. Infection and Immunity 65(5): 1980–1984.PubMed
10.
Sandros, J., C. Karlsson, D.F. Lappin, et al. 2000. Cytokine responses of oral epithelial cells to Porphyromonas gingivalis infection. Journal of Dental Research 79(10): 1808–1814.PubMedCrossRef
11.
Guarner, F., G. Perdigon, G. Coerthier, S. Salminen, B. Koletzko, and L. Morelli. 2005. Should yoghurt cultures be considered probiotic? British Journal of Nutrition 93: 783–786.PubMedCrossRef
12.
Bonifait, L., F. Chandad, and D. Grenier. 2009. Probiotics for oral health: myth or reality? Journal of the Canadian Dental Association 75(8): 585–590.PubMed
13.
Rokka, S., S. Myllykangas, and V. Joutsjoki. 2008. Effect of specific colostral antibodies and selected lactobacilli on the adhesion of Helicobacter pylori on AGS cells and the Helicobacter-induced IL8 production. Scandinavian Journal of Immunology 68(3): 280–286.PubMedCrossRef
14.
Riedel, C.U., F. Foata, D. Philippe, et al. 2006. Anti-inflammatory effects of bifidobacteria by inhibition of LPS induced NF-kappa B activation. World Journal of Gastroenterology 12(23): 3729–3735.PubMed
15.
Park, M.S., M.J. Kim, and G.E. Ji. 2007. Assessment of lipopolysaccharide binding activity of Bifidobacterium and its relationship with cell surface hydrophobicity, autoaggregation, and inhibition of interleukin-8 production. Journal of Microbiology and Biotechnology 17(7): 1120–1126.PubMed
16.
Meurman, J.H. 2005. Probiotics: Do they have a role in oral medicine and dentistry? European Journal of Oral Sciences 113: 188–196.PubMedCrossRef
17.
Sookkhee, S., M. Chulasiri, and W. Prachyabrued. 2001. Lactic acid bacteria from healthy oral cavity of Thai volunteers: Inhibition of oral pathogens. Journal of Applied Microbiology 90(2): 172–9.PubMedCrossRef
18.
Kõll-Klais, P., R. Mändar, E. Leibur, et al. 2005. Oral lactobacilli in chronic periodontitis and periodontal health: Species composition and antimicrobial activity. Oral Microbiology and Immunology 20(6): 354–361.PubMedCrossRef
19.
Zhao, J.J., K.Y. Le, X.P. Feng, and L. Ma. 2011. Antagonistic effects of Lactobacillus acidophilus and Bifidobacterium adolescents on periodontal pathogens in vitro. Shanghai Kou Qiang Yi Xue 20(4): 364–367. In Chinese.PubMed
20.
Figueredo, C.M., M.S. Ribeiro, R.G. Fischer, et al. 1999. Increased interleukin-1beta concentration in gingival crevicular fluid as a characteristic of periodontitis. Journal of Periodontology 70(12): 1457–1463.PubMedCrossRef
21.
Sakai, A., M. Ohshima, N. Sugano, et al. 2006. Profiling the cytokines in gingival crevicular fluid using a cytokine antibody array. Journal of Periodontology 77(5): 856–864.PubMedCrossRef
22.
Zhong, Y., G.D. Slade, J.D. Beck, et al. 2007. Gingival crevicular fluid interleukin-1beta, prostaglandin E2 and periodontal status in a community population. Journal of Clinical Periodontology 34(4): 285–293.PubMedCrossRef
23.
Aggarwal, B.B., G. Sethi, A. Nair, et al. 2006. Nuclear factor-kappa B: A holy grail in cancer prevention and therapy. Current Signal Transduction Therapy 1(1): 25–52.CrossRef
24.
Naganuma, K., S. Amano, H. Takeda, et al. 2000. Role of transcriptional factor activation protein-1 in endogenous expression of the interleukin-1 beta gene involved in Porphyromonas gingivalis fimbria-stimulated bone resorption in the mouse calvarial system. Oral Microbiology and Immunology 15(1): 53–57.PubMedCrossRef
25.
Nakaya, H., G. Oscawa, W. Iwasaki, et al. 2000. Effects of bisphosphonate on matrix metalloproteinase enzymes in human periodontal ligment cells. Journal of Periodontology 71(7): l158–1166.CrossRef
26.
Nishikawa, M., Y. Yamaguchi, K. Yoshitake, et al. 2002. Effects of TNF alpha and prostaglandin E2 on the expression of MMPs in human periodontal ligment fibroblasts. Journal of Periodontal Research 37(3): 167–176.PubMedCrossRef
27.
Kojima, S., Y. Itoh, S. Matsumoto, et al. 2000. Membrane-type 6 matrix metalloproteinase(MT6-MMP, MMP-25) is the second glycosyl-phosphatidylinositol(GPI)-anchored MMP. FEBS Letters 480(2–3): 142–148.PubMedCrossRef
28.
Liu, J.J., and Z.M. Guan. 2007. The relationship between interleukin-6 and periodontitis[J]. Journal of Chinese Practical Diagnosis and Therapy 21(8): 602–604. In Chinese.
29.
Stathopoulou, P.G., M.R. Benakanakere, J.C. Galicia, et al. 2010. Epithelial cell pro-inflammatory cytokine response differs across dental plaque bacterial species. Journal of Clinical Periodontology 37(1): 24–29.PubMedCrossRef
30.
Yilmaz, O., A.A. Sater, L. Yao, et al. 2010. ATP-dependent activation of an inflammasome in primary gingival epithelial cells infected by Porphyromonas gingivalis. Cellular Microbiology 12(2): 188–198.PubMedCrossRef
31.
Asai, Y., Y. Ohyarna, K. Gem, et al. 2001. Bacterial fimbriae and their peptides activate human gingival epithelial cells through Toll-like receptor 2. Infection and Immunity 69(12): 7387–7395.PubMedCrossRef
32.
Darveau, R.P., C.M. Belton, R.A. Reife, et al. 1998. Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infection and Immunity 66(4): 1660–1665.PubMed
33.
Huang, G.T., D. Kim, J.K. Lee, et al. 2001. Interleukin-8 and intercellular adhesion molecule 1 regulation in oral epithelial cells by selected periodontal bacteria:multiple effects of Porphyromonas gingivalis via antagonistic mechanisms. Infection and Immunity 69(3): 1364–1372.PubMedCrossRef
34.
Huang, G.T., H.B. Zhang, H.N. Dang, et al. 2004. Differential regulation of cytokine genes in gingival epithelial cells challenged by Fusobacterium nucleatum and Porphyromonas gingivalis. Microbial Pathogenesis 37(6): 303–312.PubMedCrossRef
35.
Sgouras, D.N., E.G. Panayotopoulou, B. Martinez-Gonzalez, et al. 2005. Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice. Clinical and Diagnostic Laboratory Immunology 12(12): 1378–1386.PubMed
36.
Braat, H., E.C. de Jong, J.M. van den Brande, et al. 2004. Dichotomy between Lactobacillus rhamnosus and Klebsiella pneumoniae on dendritic cell phenotype and function. Journal of Molecular Medicine 82(3): 197–205.PubMedCrossRef
Metadata
Title
Effect of Porphyromonas gingivalis and Lactobacillus acidophilus on Secretion of IL1B, IL6, and IL8 by Gingival Epithelial Cells
Authors
Jun-jun Zhao
Xi-ping Feng
Xiu-li Zhang
Ke-yi Le
Publication date
01-08-2012
Publisher
Springer US
Published in
Inflammation / Issue 4/2012
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9446-5

Other articles of this Issue 4/2012

Inflammation 4/2012 Go to the issue

OriginalPaper

Inhibition of miRNA-221 Suppresses the Airway Inflammation in Asthma

Erratum

Erratum to: Peripheral Blood Neutrophil Activity During Dermatophagoides pteronyssinus-Induced Late-Phase Airway Inflammation in Patients with Allergic Rhinitis and Asthma

OriginalPaper

Oxidized LDLs Inhibit TLR-induced IL-10 Production by Monocytes: A New Aspect of Pathogen-Accelerated Atherosclerosis

OriginalPaper

Apigenin Inhibits the Expression of IL-6, IL-8, and ICAM-1 in DEHP-Stimulated Human Umbilical Vein Endothelial Cells and In Vivo

OriginalPaper

Pharmacological and Pharmacokinetic Studies with Agaricoglycerides, Extracted from Grifola frondosa, in Animal Models of Pain and Inflammation

OriginalPaper

Quercetin Inhibits IL-1β-Induced Proliferation and Production of MMPs, COX-2, and PGE2 by Rheumatoid Synovial Fibroblast
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits